1. O’Reilly, D. R., Muller, L. K. and Luckow, V. A. (1994) Baculovirus Expression Vectors: A Laboratory Manual, Oxford University Press, pp. 132–34.
2. Liu, T. C., Hallden, G., Wang, Y., Brooks, G., Francis, J., Lemoine, N. and Kirn, D. (2004) An E1B-19 kDa gene deletion mutant adenovirus demonstrates tumor necrosis factor-enhanced cancer selectivity and enhanced oncolytic potency. Mol Ther
9, 786–803.
3. Reed, L. and Muench, h. (1938) A simple method for estimating fifty percent endpoints. Am J Hyg
27, 858–63.
4. Wang, Y., Thorne, S., Hannock, J., Francis, J., Au, T., Reid, T., Lemoine, N., Kirn, D. and Hallden, G. (2005) A novel assay to assess primary human cancer infectibility by replication-selective oncolytic adenoviruses. Clin Cancer Res
11, 351–60.
5. Bancroft, J.D. and Gamble M. (Ed). (2002) Theory and Practice of Histological Techniques (5th Edition), Churchill Livingstone, pp. 63–139.